The Future of Presbyopia Drops - Summary - MDSpire

The Future of Presbyopia Drops

An update on the expanding category of topical drugs to treat presbyopia.

  • By

  • Jennifer Ponte Canning, Managing Editor

  • April 1, 2025

  • 8 min

Share

Objective:

To provide an update on the expanding category of FDA-approved eye drops for the treatment of presbyopia.

Approach:
    Key Findings:
    • Ensure findings are directly linked to the source material.
    Interpretation:

    The presbyopia treatment landscape is evolving with multiple new formulations showing potential benefits, indicating a growing market for non-surgical options.

    Limitations:
    • Specify age-related limitations in the context of treatment suitability.
    Conclusion:

    The future of presbyopia drops looks promising with ongoing developments and approvals, potentially offering improved options for patients.

    Sources:

Original Source(s)

The Future of Presbyopia Drops

  • by Jennifer Ponte Canning, Managing Editor

  • April 1, 2025

Related Content

Lenz Therapeutics Announces FDA Approval of Vizz for the Treatment of Presbyopia

Near vision improvements were demonstrated within 30 minutes and lasted up to 10 hours in clinical trials.

  • July 8, 2025

  • 2 min
Evaluating Postoperative Visual Performance and Reading Abilities of a Non-Diffractive EDOF IOL Compared to a Monofocal IOL: A Randomized Controlled Study on Eye Movements

Training Staff for the Presbyopia Journey

Presbyopia isn’t new—but the way we treat it has changed dramatically. As we continue to embrace these advancements, let’s also commit to the one constant that always makes a difference: a well-trained, well-informed team.